HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer
2022 · EBioMedicine · 25 citations
https://doi.org/10.1016/j.ebiom.2022.104205
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
15
Papers
126
Citations
4
h-index
4
i10-index
Tamoor Usman is an academic researcher from Mid Cheshire Hospitals NHS Foundation Trust. The author has contributed to research in topics: Breast Cancer Treatment Studies & Breast Lesions and Carcinomas & Global Cancer Incidence and Screening. The author has an h-index of 4, co-authored 13 publications.
ORCID: 0009-0000-5315-7915Click to start Chat